H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $15

Moomoo NewsNov 26 06:34 ET · Ratings

Express News | Eton Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $15 From $11

ReutersNov 26 06:07 ET

Eton Pharmaceuticals Has Acquired The Us Rights To Amglidia (Glyburide Oral Suspension, Known As Glibenclamide In Europe) For Neonatal Diabetes Mellitus From AMMTeK, Potential US Marketing Application Submission Expected In 2026

BenzingaNov 25 06:52 ET

Express News | Eton Pharmaceuticals Inc - Plans FDA Meeting in Q1 2025, Nda Submission in 2026

ReutersNov 25 06:50 ET

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Eton PharmaceuticalNov 25 00:00 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET